Linked Life Data

10451239

Source:http://linkedlifedata.com/resource/pubmed/id/10451239

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-9-22
pubmed:abstractText
Cardiac markers have progressed from measurement of enzymes such as serum glutamate oxaloacetate transaminase and creatine kinase isoenzymes to structural proteins such as cardiac troponin. The utility of biomarkers have evolved from diagnosis of cardiac injury to assessment of the prognosis of patients with unstable angina. While cardiac angiography can serve as the gold standard for coronary anatomy, it is inadequate for detecting active myocardial damage. The finding of a typical rising and falling pattern of a highly specific biochemical marker in blood such as cardiac troponin will likely be the best indicator for detection of myocardial cell necrosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0009-8981
pubmed:author
pubmed:issnType
Print
pubmed:day
30
pubmed:volume
284
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
127-34
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Clinical application of markers of cardiac injury: basic concepts and new considerations.
pubmed:affiliation
Jewish Hospital Heart and Lung Institute, Louisville, KY 40202, USA. jadams03@sprynet.com
pubmed:publicationType
Journal Article